Informations sur le produit
- 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
- 3-Cyano-N-(2,5-diphenyl-2H-pyrazol-3-yl)-benzamide
- 3-Cyano-N-(2,5-diphenylpyrazol-3-yl)benzamide
- Benzamide, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)-
- Cdppb
Applications CDPPB is a glutamate metabotropic (mGluR5) positive allosteric modulator, used in the treatment of Phelan-McDermid syndrome caused by 22qI3 deletion. Studies have shown that CDPPB suppresses the increase of LDH release and caspase-3 activation induced by traumatic neuronal injury.
References Chen, T. et al.: Neurochem. Res., 37, 983 (2012); Rodriguez, A. et al.: Bioorg. Med. Chem. Lett., 22, 7388 (2012); Gregory, K. et al.: Mol. Pharmacol., 82, 860 (2012)